LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4th, 2018
Tag: LineaRx
LineaRx Provides Cost and Quality Advantages to Technogenetics
November 7th, 2018
At LineaRX, Putting The Horsepower Behind The CAR T
October 17th, 2018
Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16th, 2018
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1st, 2018
With New Spinoff, Biotech Goes All-In On DNA Sales
September 19th, 2018
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18th, 2018